United Orthopedic Corporation (TPEX:4129)

Taiwan · Delayed Price · Currency is TWD

71.30

-1.20 (-1.66%)

Nov 6, 2026, 1:30 PM CST

Market Cap	6.88B -44.9%
Revenue (ttm)	6.07B +19.1%
Net Income	551.28M +10.8%
EPS	5.49 +6.6%
Shares Out	96.44M
PE Ratio	12.99
Forward PE	10.97
Dividend	4.50 (6.31%)
Ex-Dividend Date	Jul 23, 2026

Volume	180,953
Open	71.50
Previous Close	72.50
Day's Range	68.30 - 72.10
52-Week Range	68.30 - 131.50
Beta	0.45
Analysts	Buy
Price Target	114.75 (+60.94%)
Est. Earnings	Nov 10, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, rest of Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized art... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1993

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 4129

Full Company Profile

Financial Performance

In 2025, United Orthopedic's revenue was 5.66 billion, an increase of 21.54% compared to the previous year's 4.65 billion. Earnings were 562.02 million, an increase of 23.14%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 4129 stock is "Buy." The 12-month stock price target is $114.75, which is an increase of 60.94% from the latest price.

Price Target

$114.75

(60.94% upside)

Analyst Consensus: Buy

Stock Forecasts